Trial Profile
Phase I Trial of The Combination of Vismodegib and Sirolimus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Vismodegib (Primary)
- Indications Adenocarcinoma; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- 04 Apr 2019 Status changed from suspended to completed.
- 05 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 05 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.